Clorox (CLX) Cash & Equivalents (2009 - 2026)

Clorox's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 425.22% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 425.22% YoY), while the FY2025 annual figure was $167.0 million, down 17.33% from the prior year.
• Cash & Equivalents was $1.2 billion for Q1 2026 at Clorox, up from $227.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.2 billion in Q1 2026 to a low of $166.0 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $312.6 million across 5 years, with a median of $241.0 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents slumped 51.02% in 2022, then jumped 425.22% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $168.0 million in 2022, then soared by 111.31% to $355.0 million in 2023, then decreased by 18.31% to $290.0 million in 2024, then slipped by 21.72% to $227.0 million in 2025, then jumped by 422.91% to $1.2 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.2 billion (Q1 2026), $227.0 million (Q4 2025), and $166.0 million (Q3 2025), per Business Quant data.